Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores

Overview of attention for article published in Breast Cancer Research, April 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 1 policy source

Readers on

mendeley: 35 Mendeley

Summary Policy documents

So far, Altmetric has seen 2 policy documents that reference this research output.

Genuttrycksprofil för beslut om adjuvant cytostatikabehandling vid hormonkänslig, HER2-negativ bröstcancer

Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on 11 Jun 2019

SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects.

Genuttrycksprofil för beslut om adjuvant cytostatikabehandling vid hormonkänslig, HER2-negativ bröstcancer

Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on 11 Jun 2019

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.